Capillary Electrophoresis Buffer for HbA1c Separation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for analyzing glycated hemoglobins, particularly HbA1c, by capillary electrophoresis face challenges in effectively separating HbA1c from other hemoglobins and minor fractions, leading to interference and inaccurate results due to similarities in electrophoretic mobility and co-migration.
Innovation Solution
A capillary electrophoresis method using a specific buffer composition that complexes glucose residues of glycated hemoglobins with a compound capable of providing negative electrical charges at alkaline pH, enhancing the separation of HbA1c by altering its electrophoretic mobility and allowing it to be distinguished from other hemoglobins.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional capillary electrophoresis methods are used to analyze glycated hemoglobins, then the analysis can be performed with standard buffer compositions, but the separation between HbA1c and other hemoglobins is insufficient leading to co-migration and inaccurate results
Solution Approach 1:
The patent changes the chemical parameters of the buffer composition by introducing compounds containing boronate groups (such as phenylboronic acid or its derivatives) at controlled pH levels (8.0-10.0). These parameter changes enable specific complexation with glucose residues of glycated hemoglobins, altering their electrophoretic mobility and achieving baseline separation between HbA1c and other hemoglobin fractions, thereby resolving the co-migration issue and improving both measurement precision and reliability
2Productivity
If standard capillary electrophoresis buffer compositions are used, then the method is simple and rapid, but interference from minor fractions and other hemoglobins prevents accurate HbA1c analysis
Solution Approach 1:
The patent introduces boronate-containing compounds as intermediary substances that selectively bind to glucose residues of glycated hemoglobins. These intermediaries act as mediators between the electrophoresis system and the target analyte (HbA1c), creating stable complexes with distinct electrophoretic properties that enable accurate detection and quantification while maintaining the rapidity of capillary electrophoresis analysis
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method provides a reliable and accurate semi-quantitative or quantitative analysis of glycated hemoglobins, including HbA1c, by effectively separating it from other hemoglobins and minor fractions, improving diagnostic and monitoring capabilities for diabetes.
Implementation Method 1
A method for analyzing, by capillary electrophoresis, glycated hemoglobins (one or more) containing one or more glucose residues
Implementation Method 2
the separation of the constituents of said biological sample by capillary electrophoresis
Implementation Method 3
a buffer composition comprising at least one compound capable of specifically complexing glucose residues of glycated hemoglobins and of providing them with several negative electrical charges at alkaline pH
Data Source
Figure 1
Figure 2
Figure 3
AI summary
The invention relates to a method for the analysis of glycated hemoglobins by capillary electrophoresis, said glycated hemoglobins comprising at least one globin chain including a glucose residue bonded to the amino acid in the N-terminal position and being contained in a biological sample, wherein said method includes the implementation of a buffer composition including at least one compound capable of specifically complexing glucose residues of one or more glycated hemoglobins and conveying, to said hemoglobin(s), a plurality negative electric charges having an alkaline pH. For example, said compound can be 3,4- or 3,5-dicarboxyphenylboronic acid, preferably 3,5-dicarboxyphenylboronic acid. Said method can particularly be used for separating and assaying the HbAi0 hemoglobin present in a biological sample optionally comprising other hemoglobins, in particular other minor fractions. The invention also relates to buffer compositions useful for said analysis, as well as to kits for analyzing and assaying glycated hemoglobins by capillary electrophoresis.